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Abstract
Follicular dendritic cells (FDC) store native antigen for long periods In lymphoid follicles and so
provide a source of continued stimulation for specific B cells. The expression of MHC class II by
FDC suggested they might act as antigen-presenting cells for MHC class ll-restricted T cells. We
show here, however, that the MHC class II molecules found on their surface are not synthesized
by the FDC but are picked up from surrounding B cells In germinal centres. Although FDC by
themselves cannot present native antigen to T cells, acquired MHC class II - peptlde complexes
can be recognized by T cells. The true physiological role of FDC seems to be as long-term
antigen depots. We demonstrate that antigen localized onto FDC In vivo can be retrieved by
antigen-specific B cells, which In turn process and present It to T cells. These presentation
pathways are likely to be crucial In both the maintenance of long-term Immune responses and
the continued survival of memory cells.
Introduction
The survival of memory B lymphocytes over long periods seems
to require the continued presence of antigen (1). While this may
occur via recurrent infection with the same or similar organisms
(2,3), there are specialized cells within secondary lymphoid
organs that can store antigens for long periods (4,5). These cells
are follicular dendritic cells (FDC) that form a structural network
within B cell follicles. During antibody responses, antigen -
antibody complexes are deposited via Fc (6) or C3 (7) receptors
on the surface of FDC (8,9). The immediate consequence of this
deposition is the formation of germinal centers, foci of rapidly
proliferating B ceils that represent the clonal expansion of memory
B cells (10,11). The germinal center reaction, however, is transient
but FDC carrying intact antigen on their surface persist for long
periods (4,5). As long-term stores of antigen, it seems likely that
they play a crucial role both in the maintenance of long-term
antibody responses (12) and the continued survival of memory
B cells (1).
Data now emerging (13,14; D. Gray and P. Matzinger, sub-
mitted for publication) suggest that memory T cells, as well as
B cells, depend upon periodic antigen stimulation for their long-
term survival. The depots of antigen on FDC would be prime
candidates as the source of this stimulation. However, it is not
clear whether FDC could present this antigen directly to T cells
or whether an intermediate antigen-processing B cell is required.
Firstly, FDC are restricted to B cell follicles, areas that contain
only small and possibly selected subsets of T cells (15-17).
Secondly, current knowledge of antigen handling by FDC would
indicate that they do not process antigen. Paradoxically, although
they express MHC class II on the surface (18,19), a prerequisite
for antigen presentation, ultrastructural studies have shown that
antigens are not internalized (20,21).
In this report we investigate the functional capacity of FDC as
antigen-presenting cells to both T and B cells. We show that while
B cells recognize antigen stored on FDC directly, a unique
pathway of antigen transfer from FDC to B cells allows processing
and presentation to T ceils. This provides a means by which both
memory B cells and memory T cells receive persistent stimulation.
Methods
Animals
BALB/c, CBA/J, C3H, and C57BL/6 mice were purchased from
Iffa-Credo (Lyon, France). B10.D2, (CBA x BALB/c)F,. and
(C3H x DBA/2)F, mice were bred and maintained at the Basel
Institute for Immunology breeding facility', Kaiseraugst. Sma58
transgenic (22) mice were kindly provided by Dr Diane Mathis
(CNRS-INSERM, Strasbourg, France).
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Bone marrow chimeras
Two types of chimeras were used in this study. Firstly, to study
antigen presentation by FDC to T cells we constructed parent
— F, chimeras; these were termed FDC/bone marrow
chimeras. Secondly, to study the origin of MHC class II on the
FDC surface we used fully allogeneic bone marrow chimeras.
Both types of chimeras are described in detail below,
(i) FDC/Bone marrow chimeras were constructed in the following
way: Host (CBA x BALB/c)F, mice were immunized three
times, 2 weeks apart, twice with 250 ng alum-precipitated
dinitrophenylated ovalbumin (DNP-OVA) plus 5X108 killed
Bordetella pertussis above each footpad, and finally with 250
HQ soluble DNP-OVA. Ovalbumin was fraction V (Sigma
Chemical Co., St. Louis, MO) and was DNP-labeled (substitu-
tion ratio 9:1) as described previously (23). Three days after
the final boost, the mice were lethally irradiated (950 cGy from
a 137Cs 7 source; Atomic Energy Canada Ltd, Ottawa) and
reconstituted with 2x10 7 anti-Thy1.2 (6.68 McAb; 24) plus
complement-treated bone marrow cells from CBA mice Five
weeks later reconstitution was assessed in tissue sections and
cell suspensions from lymph nodes using immunofluorescence
staining with the following antibodies: 14.8 (anti-B220, B cells;
25), F4/80 (anti-macrophage; 26), 4C11 (anti-FDC; M. Kosco
and D. Gray, manuscript in preparation), 21.460 (anti-
H-2Dd'b, host class I; a gift from Dr G. J. HSmmerling, Depart-
ment of Immunology, DKFZ, Heidelberg), MK-D6 (anti-l-A^,
host class II; 27), and 14.4.4 (anti-l-E^ host and donor class
II; 28). Staining is described in detail in the next section. Two
days before the popliteal, brachial, and axillary lymph nodes
were taken, mice were given 600 cGy irradiation,
(ii) Allogeneic bone chimeras were constructed as follows:
C57BU6 mice were lethally irradiated (950 cGy) and
reconstituted with 2 x 107 T cell-depleted bone marrow cells
from B10.D2 donors (H-2« - H-2»). Three weeks after
reconstitution, chimeras were immunized in the footpad to
generate germinal centers. Antibodies used for staining of
tissue sections were: 14.4.4-biotin (anti-donor MHC class II,
28) and R1.21.2 (anti-H2», host MHC class I; obtained from
Dr G. J. Hammerling, Department of Immunology, DKFZ,
Heidelberg).
Immunohistology
Lymphoid organs were frozen in liquid nitrogen and mounted
for cryostat sectioning. Four micron sections were dried and
acetone-fixed, and then co-incubated with the requisite first stage
antibodies listed in other sections. First stage antibodies were
a combination of mouse monoclonal antibodies that were biotin-
labeled and rat monoclonal antibodies. These were revealed by
co-incubation with streptavidin-Texas red (Southern
Biotechnology Associates, Birmingham, AL) and polyclonal rat
anti-mouse IgG conjugated to fluorescein isothiocyanate (FITC)
(Jackson Immuno Research Labs, Hamburg, FRG). Slides were
viewed on a Zeiss Axiophot fluorescence microscope using
580-585 nm and 450-490 nm filters for Texas red and FITC
respectively. Some sections were analyzed on a BioRad 600
Scanning Laser Confocal Microscope, scanning at 0.5 fim levels.
FDC isolation
FDC were isolated using a procedure that is essentially the same
as that described by Schnizlein et al. (29). This consists of enzyme
digestion of lymph nodes followed by density gradient centrifuga-
tion. Cells harvested from the top of the 1.063 g/ml density BSA
(Bovine Serum Albumin, Path-o-cyte, Elkhart, IN) were incubated
on tissue culture plates for 2 h at 37°C to deplete macrophages
and lymphoid dendritic cells. Because FDC cluster readily with
B cells during isolation (30), we reduced the number of B cells
contaminating the FDC preparations by irradiating (600 cGy) the
mice 2 days pnor to use.
Antigen presentation by FDC
FDC-containing cell suspensions from parent — F, bone
marrow chimeras described previously were plated in round-
bottomed 96-well plates (Costar) in Iscove's modified Dulbecco
medium supplemented with 10% FCS, 5 x 1 0 - 5 M mercapto-
ethanol, 2x 10~3 M L-glutamine, and 100 ^g/ml gentamycin. In
order that the T cell hybrid could come into close contact with
the FDC, we reduced B cell numbers in the cell preparations
by irradiation (600 cGy) of the mice 2 days prior to killing. Serial
dilutions of FDC starting from 5x 104 cells/well were irradiated
(3200 cGy) and incubated with the T cell hybrid 4E12 (5x 104/
well). This hybrid was generated by fusion of a clone derived
from a B10.D2/0 mouse immunized with OVA (grade V, Sigma)
with the TlymphomaBW 5147. 4E12 recognizes antigen in the
context of I-Ad and is stimulated by antigen doses < 1 ^g/ml.
Transfer of MHC class II molecules from B cells to FDC in vitro
B cells were prepared from suspensions of lymph node and
spleen from BALB/c (H-2 )^ or C57BL/6 (H-2b) mice by depletion
with anti-Thyl .2 and complement. B cells were stimulated with
LPS (100 ftg/ml: Salmonella typhosa 0901; Difco Laboratories,
Detroit, Ml) plus 1 % IL-4 containing supernatant (31) at
2x10-6/ml in 24-well costar plates. After 48 h, supernatants
were harvested and incubated with FDC from C57BL/6 (H-2*>)
mice together with a defined OVA peptide (323-339: 0.5 pM)
which is recognized in the context of I-Ad by the OVA-specific
T cell hybrid 3DO-548 (32). Eighteen hours later the FDC were
irradiated and responder T cells added (SxiCH/well). T cell
activation was measured by interieukin 2 (IL-2) release after a
further 24 h of culture. One hundred microhters of supernatants
were transferred to fresh microtiter plates, together with 5 x 103
indicator cells/well (IL-2 dependent T cell line, CTLL). After
another 24 h culture period, 1 ^Ci/well [3H]thymidine was added
and incorporation of thymidine was assessed 6 h later in a liquid
scintillation counter.
Antigen transfer from FDC
In this assay we are asking if antigen localized on the surface
of an FDC in vivo can be transferred to an allogeneic B cell for
subsequent processing and presentation to a T cell hybrid. CBA
(H-2k) mice were immunized twice with 250 HQ of alum-
precipitated DNP-OVA + B. pertussis and once with 250 HQ
soluble antigen above four foot pads. Four days later, FDC
preparations were made. DNP-specific and keyhole limpet
hemocyanin (KLH)-specific B cells were prepared from lymph
nodes of BALB/c (H-2d) mice immunized 7 -10 days previously
above each footpad with 250 /»g alum-precipitated DNP-KLH or
KLH plus B. pertussis by depletion of T cells with anti-Thyl +
complement treatment. FDC were serially diluted from 5x 104
cells/well. B cells were added at 1 x 10rwell in 96-well round-
bottomed culture plates (Costar), and FDC and B cells were then
incubated for 4 h at 37°C prior to irradiation with 3200 cGy and
addition of the T cell hybrid, 4E12, (SxiCWwell). In some
experiments we assayed the transfer of DNP-KLH, localized
in vivo onto FDC to DNP-specific B cells and subsequent pro-
cessing and presentation to a KLH-specific T cell hybrid, 10H/
A.H. This T cell hybrid was derived by fusing T cell clone 10H/A
(33) (kindly provided by Dr Peter Erb, Department of
Microbiology, University of Basel) with the T cell lymphoma,
BW5147. T cell activation was measured as described in the
previous section.
Results
Antigen presentation by FDC
A technical problem encountered when testing the capacity of
FDC to process and present antigen is their close contact with
B cells, which are very efficient antigen-presenting cells. To cir-
cumvent antigen presentation by contaminating B cells, we took
advantage of the fact that FDC are not derived from bone marrow
cells (34) and constructed parent — F, chimeras in which only
non-hemopoietic cells such as FDC carry host H-2.
CBA x BALB/c (H-2k x H-2d) hosts received three s.c. injections
of DNP-OVA at weekly intervals before they were lethally
irradiated and reconstituted with CBA bone marrow. After
reconstitution, T cells, B cells, and myeloid cells were of donor
(H-2k) origin whereas FDC remained of host origin (data not
shown). We then asked if FDC prepared from the lymph nodes
of these animals would present OVA directly to the I-Ad-
restricted, OVA-specific T cell hybrid, 4E12.
In three experiments FDC failed to activate the T cell hybrid,
even when exogenous antigen (DNP-OVA) was added to the
cultures. Due to the essentially negative result, these data are
not shown, while the experimental system is illustrated in Fig. 1.
Immunohistological staining of lymph node sections from these
chimeras unexpectedly showed that there was no host I-Ad
associated with FDC, thus providing a rational explanation for
the failure of antigen presentation.
FDC/BONE MARROW CHIMAERAS
IN VIWD
Fig. 1 . Schematic diagram of the functional test of antigen processing
and presentation by FDC.
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MHC class II expression by FDC
The lack of expression of MHC class II by FDC in these chimeras
conflicted with the published data (18,19). We therefore
investigated class II expression by FDC further. A convenient tool
for these studies was a transgenic mouse line developed by
D. Mathis and colleagues (22). Sma58 mice were derived by
injection of an I-Ea construct into a recipient strain that has silent
I-Ea genes due to a deletion in the promoter region
[(C57BL/6xSJL)F2] Deletions in the'B cell control'region 1 - 2
kb upstream of the Ea construct result in aberrant expression in
B cell populations, such that peripheral, recirculating (resting)
B cells express no I-E while B cells in germinal centers do. The
expression of the transgene in myeloid cells (macrophages and
dendritic cells/interdigitating cells) is normal (22). This allowed
us to study MHC class II expression on FDC in the absence of
expression on B cells. It was also imperative for these studies
to have a reliable marker for FDC. We have recently obtained
a monoclonal antibody, 4C11, raised by immunizing rats with
mouse FDC preparations; while this will be described elsewhere
(M. Kosco and D. Gray, manuscript in preparation), it can be seen
from Fig. 2(a) that it is specific for FDC in lymphoid (B cell) follicles
and recognizes nothing outside these structures. Figure 2(a)
shows that in resting, primary follicles of spleen and lymph nodes
of transgenic mice where the B cells express no I-E, the FDC
are also negative In contrast, when the B cells up-regulate the
transgene in an antigen-driven germinal center, the FDC also
become l-E-positive (Fig. 2b).
There are two possibilities that would explain this result. Either
FDC do not synthesize I-E themselves, but rather pick it up from
surrounding B cells, or they up-regulate I-E in the same manner
as germinal center B cells. To distinguish these two possiblities,
we set up allogeneic bone marrow chimeras [B10.D2 (H-211) —
C57BL/6 (H-2b)]. Figure 2(c) shows the staining of lymph node
sections of a chimera, 4 weeks after reconstitution, with antibodies
that detect FDC (4C11) and host MHC class I. The complete
overlap of staining is visualized by the yellow color (mix of red
and green). Figure 2(d) shows staining of the same tissue with
4C11 and an antibody to detect donor I-Ad. Again, there is a
complete overlap of this staining pattern. Figure 2(e) shows
double staining for host class I and donor class II on the same
section analyzed by confocal microscopy. The staining patterns
we observe support the conclusion that MHC class II on FDC
is picked up from B cells. However, immunofluorescence staining
of tissue sections does not allow us to state unequivocally that
the 4C11 epitope and class II are actually expressed on the same
membrane. To further substantiate this hypothesis, we attempted
to detect transferred class II on the FDC in vitro.
FDC pick up MHC class II shed by B cells
Rather than trying to detect donor MHC class II on isolated FDC
from the allogeneic chimeras described in the previous section,
we attempted to detect absorbed class II using a functional assay.
The up-regulation and shedding of class II by B cells as it occurs
in germinal centers can be mimicked in vitro by stimulation with
lipopolysaccharide together with IL-4 (35). Overnight we
incubated supernates from stimulated H-2d B cells with FDC
from H-2b mice and a defined ovalbumin peptide (323-339)
recognized by the T cell hybrid, 3DO-548. Table 1 shows that
H-2b FDC were unable to present peptide to the T cell hybrid.
Upon incubation with supernatant from H-2d but not H-2b mice,
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Table 1. FDC pick up MHC class II shed by B cells
APC
FDC
H-2b
Class II
source B cell
supernatant
H-2«conc.
1:3
1.9
cone
H-2b cone.
Antibody added
_
-
MK-D6 (antHl-A<0
-
IL-2 production
by anti-OVA
T cell hybrid
(c.p.m.)
15,801
5231
870
925
571
FDC could now activate the T cell hybrid. This effect was dose-
dependent and inhibited by anti-l-Ad antibodies. The results
clearly show that FDC are able to pick up MHC class II and can
use them for direct presentation to T cells.
FDC can present but do not process antigen
If one considers that MHC class II molecules are almost always
occupied by peptides, the acquisition of such class II + peptide
complexes from B cells might enable FDC to present directly to
T cells. We found that in one group of parent — F, chimeras
similar to those depicted in Fig. 1 [C3H (H-2*) - C3H x DBA/2
(H-2kxH-2d)], FDC obtained 5 weeks after reconstitution were
able to activate the I-Ad-restricted anti-OVA T cell hybrid, 4E12
(Table 2, group A). Staining of lymph node sections from these
chimeras showed that the only cells carrying host I-Ad were FDC
(data not shown). Thus, class II originally picked up from host
B cells had persisted for 5 weeks on the FDC surface and was
able to stimulate a T cell hybrid. Addition of exogenous antigen
to the FDC during culture did not increase the response (Table
2, group A), consistent with the notion that FDC do not themselves
process antigen.
Antigen transfer from FDC to B cells
Since FDC do not process antigen, B cells would be crucial for
providing antigen in a form suitable for T cell recognition.
Therefore, native antigen stored on FDC must be transferred to
B cells for processing. To show that such an antigen transfer is
functionally possible, we localized antigen (hapten-carrier
conjugate) onto FDC in vivo, made cell preparations enriched
for FDC, and tested in vitro if the hapten-carrier conjugate could
be picked up by haptervspecific B cells and presented to a
carrier-specific T cell hybrid. To circumvent the problem of
antigen-presenting B cells contaminating the FDC preparation
we used ailogeneic combinations of FDC and B cells. FDC
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donors (H^^ ice) were immunized twice with DNP-OVA and
then given 600 cGy irradiation 48 h prior to set up in vitro.
Irradiation reduces the number of B cells in the FDC prepara-
tion as these tend to form clusters with FDC during isolation and
prevent access of the antigen-presenting B cells added in vitro.
The B cells added to the cultures came from H-2d mice
immunized with the hapten coupled to an unrelated carrier (DNP-
hemocyanin, KLH). The responding T cell hybrid, 4E12,
recognizes OVA in the context of I-Ad.
Figure 3 shows that the combination of FDC bearing DNP-OVA
immune complexes and B cells specific for DNP-KLH was
capable of stimulating IL-2 secretion by the OVA-specific T cell
hybrid without the requirement for any further addition of antigen
to the culture. Neither FDC bearing inappropriate MHC class II
nor B cells alone could activate the hybrid. DNP-OVA added to
the culture was efficiently presented by DNP-KLH immune B cells.
The transfer of DNP-OVA from FDC to B cells was dependent
upon the hapten specificity of their antigen receptor. Within the
dose range shown, B cells from mice primed with KLH only did
not pick up and present DNP-OVA from the FDC (Fig. 3).
Only antigen stored on FDC was available for B cell presenta-
tion. Macrophages and interdigitating cells isolated as adherent
cells from DNP-OVA-immune H-2k mice did not function as
antigen depots and no transfer to H-2d B cells was observed
in vitro (Table 2, group B). The passage of antigen from FDC
to B cells is not unique to DNP-OVA and the OVA-specific T cell
hybrid, but can occur using a different antigen (DNP-KLH) and
a different T cell hybrid, 10H/A.H, specific for KLH + I-A"
(Table 2, group C).
Discussion
The experiments described in this paper were designed to
investigate the mechanisms of antigen handling in B cell follicles.
The antigen in these sites is of critical importance during at least
two phases of the immune response. During the primary
response ( 5 - 7 days after immunization) antigen-antibody
complexes become deposited onto the surface of FDC, initiating
the germinal center reaction that generates memory B cells
(10,11). Later, in the established phase of antibody responses,
the immune complex on FDC is likely to be a stimulus for
continued serum antibody production (12,36) and for the
maintenance of memory B cells (1). Growing evidence that T cell
memory is likewise dependent upon antigen persistence
(13,14,37; D. Gray and P. Matzinger, manuscript submitted) led
us to investigate how antigen localized on FDC would be
accessible for the stimulation of T cells.
Fig. 2. MHC class II expression by follicular dendritic cells, (a) A primary B cell follicle in the spleen of a Sma58 transgenic mouse stained to show
I-Ek transgene expression (red) and FDC (green). FDC here do not express the transgene. (b) A germinal center in the spleen of a Sma58 mouse
7 days after immunization with alum-precipitated DNP-OVA. Double staining for I-Ek (red) and FDC (green) shows that there is extensive overlap
(yellow); the arrow indicates an FDC that expresses I-E* only on the dendritic processes that contact an I-E^positive B cell and not on those that
do not. (c) The staining for class host I (red) and FDC (green) in a germinal center in a lymph node from an ailogeneic bone marrow chimera 4 weeks
after reconstitution. The yellow color (red/green overlap) shows the expression of both markers on FDC; it should be noted that the dendritic, reticular
pattern is characteristic of FDC staining and not the ring-like staining of B cells, (d) The staining for donor class II (red) and FDC (green) in a germinal
center from the same lymph node as in (c); note again the complete overlap of staining (yellow), (e) A picture of a germinal center from the chimeric
mice showing host class I (green) an donor class II (red), obtained using a BioRad 600 scanning laser confocal microsocope, scanning at 0.5 ^m
levels through the section.
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Table 2.Transfer of antigen on FDC to antigen-specific B cells
Responding T cell
hybrid
Group A: 4E12
(OVA + I-A")
Group B: 4E12
(OVA + I-Ad)
Group C: 10H/A.H
(KLH + I-Ad)
Antigen localization
Cell type
"FDC
II
-
-
"
u
FDC
>
•
"
FDC
FDC
Cell no
105
—
—
5X104
n
H
"
5X104
25X104
1.25x10"
0.6 X104
5X104
2.5x10"
1.25x10"
0.6X104
5X1O4
5x10"
H-2
k + d
-
_
k
k
Antigen
DNP-OVA
n
-
-
DNP-OVA
//
II
DNP-KLH
n
"
n
«
"
ti
DNP-primed
B cells (H-2d)
added to
culture
none
none
10s
105
none
none
105
105
105
"
n
n
«
II
it
"
n
Exogenous
antigen
none
DNP-OVA
none
DNP-OVA
none
DNP-OVA
none
DNP-OVA
none
»
••
DNP-KLH
"
none
DNP-KLH
IL-2 production
[3H]thymidine
uptake (c.p.m.)
11,836
13,147
1190
41,397
329
442
228
51,398
11,365
10,191
7193
3921
14,751
14,163
15,610
16,815
587
1086
Group A- the presentation to T cells ot OVA on the surface of FDC from chimeras sim3ar to those described in Fig. 1, (C3H(H-2k) — (C3H x DBA/2)F,
(H-2kx H-2d). Lymph nodes in these mice exhibited class II of host origin (I-Ad, detected by MK-D6) associated with FDC; group B. adherent cells
(macrophages or lymphoid dendritic cells) from the donors of FDC in the antigen transfer experiment depicted in Fig. 3 do not carry antigen that
can be passed to B cells Adherent cells were cells that stuck to plastic Petn dishes during a 2 h incubation at 37°C of the FDC-ennched fraction
taken from the BSA gradient; group C. in vitro transfer of DNP-KLH localized onto FDC in vivo to DNP-specific B cells and subsequent processing
and presentation to a KLH-specific T cell hybrid, 10H/A.H
ANTIGEN TRANSFER FROM FDC APC(antigen)
O I-AkFDC + I-AdBcella
(DNP-OVA) (DNP-KLH)
O I-AkFDC + I-AdBcells
(DNP-OVA) (KLH only)
• — I-Ad Bcella
(DNP-KLH)
A I-AkFDC —
(DNP-OVA)
Tcefis
I-Ad
restr.
anti-OVA
2.5 1.25 0.6 5 ^5-1.25 0.6
Number of cells added per well (x104)
Fig. 3. In vitro transfer of antigen localization onto FDC in vivo to specific B cells.
The experiments presented here show that the FDC that
maintain antigen as an immune complex on their surface for
periods of months (4,5), and possibly years, are incapable of
processing it and presenting it to T cells. This agrees with electron
microscope studies of Szakal and colleagues in that they
observed no internalization of antigen by FDC (20,21). While we
would have liked to purify FDC to the extent that we could ask
directly if they would process and present, this proved impossible
due to the property of FDC to form clusters with contaminating
B cells, which would serve as potent antigen-presenting cells.
This problem was circumvented by the construction of parent
into F, bone marrow chimeras in which the only cell that could
potentially present directly to the l-Ad-restricted anti-OVA T cell
hybrid was an FDC. The results of the experiments were negative
with one notable exception. As a prerequisite for antigen
presentation, FDC in these chimeras required expression of the
relevant, host-type class II MHC. Analysis of the parent — F,
chimeras revealed that FDC did not express host class II, with
the exception of one group of mice. FDC in this exceptional group
stimulated T cells directly. Addition of antigen in culture did not
increase the response further, which is in agreement with the
observation that FDC do not process antigen.
Paradoxically, the immediate reason for the inability of FDC
in these chimeras to present was the lack of appropriate MHC
class II molecules on their surface, a finding in contradiction with
previous reports in the literature (18,19). The mystery was solved
by the finding that MHC class II on the surface of an FDC is not
synthesized by the cell itself but is acquired from surrounding
B cells. In line with this observation, in Sma58 transgenic mice
which have a defect in I-E expression in B cells, the FDC are
also negative for I-E except those in germinal centers where B
cells up-regulate and express the I-E transgene. Co-expression
of host class I and donor class II on FDC from allogeneic bone
marrow chimeras indicates that MHC class II molecules normally
seen on the surface of FDC are in fact derived from B cells. While
we cannot resolve unequivocally, with light microscopy on tissue
sections, whether two molecules are localized on the same
membrane, we have demonstrated that MHC class II shed from
the surface of B cells during culture is absorbed by FDC and
can stimulate an appropriately restricted T cell hybrid.
In germinal centers in normal mice, activated B cells increase
their surface class II levels by 2- to 3-fold (38), a phenomenon
that may result in the release of class II into the interstitial fluid.
In this context, activated B cells have been reported to shed class
II into culture medium (39,40). Whether the release is due to an
active process or to cell death, of which there is ample in the
germinal center (41), cannot be distinguished at present.
However, we do have preliminary data that shedding of class
II into tissue culture medium is related to the up-regulation
following stimulation with IL-4 + LPS, while in cultures stimulated
with LPS alone there is no evidence of shed class II.
Both the mechanism of uptake by FDC of shed class II and
the physiological relevance of the process remain obscure. For
the means of uptake, two mechanisms suggest themselves.
Firstly, direct membrane fusion: previous studies (40) showed
that the class II shed from activated B cells was associated with
membrane lipid (the transfer of other molecules such as class
I would be precluded). Secondly, there is evidence that MHC
class II is closely associated in the B cell membrane with CD23
(low-affinity IgE Fc receptor) (42). In a germinal center B cells
lose CD23 expression (43) while FDC in active sites express high
levels (43); it is possible that shed class II could associate with
the CD23 on the FDC. As for the relevance of this process, it
seems that FDC can stimulate T cells directly by presenting class
II - peptide complexes picked up from B cells. An in vivo example
of this is the exceptional set of parent — F, chimeras which
contained OVA-presenting FDC 5 weeks after irradiation and
reconstitution (see Table 2, Group A). The class II - OVA peptide
complexes on the surface of these ceils were of host origin picked
up from antigen-activated B cells prior to irradiation. This in vivo
observation can be mimicked in vitro by incubating FDC of
inappropriate H-2 haplotype with supernatant from stimulated
H-2^ B cells. Considering that the transfer of antigen from FDC
and subsequent processing by B cells seems to be a highly
efficient means of stimulating T cells, why should FDC present
passively acquired class II - peptide complexes? The presenta-
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tion of antigen by FDC may be a means of optimizing the
stimulation of T cells during a phase of B cdl differentiation (i.e. in
germinal centers) in which they lose surface membrane immuno-
globulin (44,45) and hence their capacity to take up antigen for
processing and presentation.
At the moment, however, we believe that the major pathway
for the presentation of antigen for the maintenance of T and B
cell responses and T and B cell memory is the one proposed
by Tew and co-workers (46-49), for which we provide experi-
mental evidence in this paper. This involves the transfer of antigen
from the surface of FDC to B cells for subsequent processing
and presentation to T cells, an interaction that would result in
proliferative, drfferentiative, or merely survival signals for both the
participants. Iccosome structures (46) on FDC dendritic
processes have been proposed as the packets of antigen that
are picked up by B cells in the early phase of the germinal center
reaction and, indeed, B cells taken ex vivo from primed mice
will present without addition of exogenous antigen to a T cell
hybrid (47). Here we demonstrate the whole process in vitro: FDC
taken from primed mice can act as a source of unprocessed
antigen only for specific B cells that in turn process and present
to T cells to close the loop of immune stimulation in germinal
centers.
In conclusion, we feel that we have demonstrated two unique
antigen presentation pathways, one of which may be important
during the development of memory in a germinal center and the
other crucial for the maintenance of secondary immune responses
and the continued survival of both B and T memory cells.
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